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Research
Since chlorination disinfection by-products
(DBPs) were ﬁrst reported in drinking water
(Rook 1974), there have been concerns about
potential adverse reproductive health effects,
including low birth weight, spontaneous abor-
tion, stillbirth, and congenital anomalies
(Nieuwenhuijsen et al. 2000a), but ﬁndings of
the studies to date have been inconsistent.
Statistically significant positive associations
have been reported between trihalomethane
(THM) exposure and neural tube defects
(NTDs) (Bove et al. 1995; Dodds and King
2001; Klotz and Pyrch 1999), major cardiac
defects (Cedergren et al. 2002; Hwang et al.
2002), urinary tract defects (Aschengrau et al.
1993; Hwang et al. 2002; Magnus et al. 1999),
and respiratory defects (Aschengrau et al. 1993;
Hwang et al. 2002), whereas other studies did
not ﬁnd such associations (Dodds et al. 1999;
Källén and Robert 2000; Shaw et al. 2003).
Studies on oral cleft or cleft palate have largely
been negative, except for the study by Bove
et al. (1995). Only Dodds and King (2001)
and Shaw et al. (2003) studied the effect of
speciﬁc THMs. Dodds and King (2001) found
a statistically significant association between
bromodichloromethane (BDCM) and NTDs,
whereas Shaw et al. (2003) found a few statisti-
cally significant negative associations with
NTDs and cleft lip and palate. One of the
main limitations in most of these studies has
been small sample size, resulting in low power
to explore exposure–response relationships.
In the present study, the largest study of
its kind so far, we report the relationships
between THM levels in the public water sup-
ply and risk of congenital anomalies across
England and Wales. Primary analyses focused
on total THM and broad categories of con-
genital anomalies; secondary analyses focused
on restricted subsets of anomalies and speciﬁc
THM groups, including bromoform and
brominated THMs. 
Methods
Study region and years. The study area was
covered by 12 water companies in the United
Kingdom: United Utilities (formerly North
West; estimated population, 6.8 million),
Severn Trent (7.6 million), Northumbrian
(2.6 million), Anglian Water (4.0 million),
Bristol (1 million), Dwr Cymru Cyfyngedig
(3 million), Essex and Suffolk (1.7 million),
Southern (2.2 million), South West (1.3 mil-
lion), Thames Water (7.4 million), Three
Valleys (2.4 million), and Yorkshire (4.2 mil-
lion) (Figure 1). Under regulations in force at
the time the THM samples were taken, water
companies divided their water supply into
water supply zones, each zone covering a popu-
lation of < 50,000 people. Less than 1% of
households in the United Kingdom have pri-
vate water supplies. We chose this study area
because it had considerable variation in THM
concentrations between water zones, and digital
water-zone boundaries were available within
geographic information systems (GIS). GIS
data were available for Northumbrian for
1997, United Utilities for 1993–1997, and
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BACKGROUND: Increased risk of various congenital anomalies has been reported to be associated
with trihalomethane (THM) exposure in the water supply.
OBJECTIVES: We conducted a registry-based study to determine the relationship between THM
concentrations and the risk of congenital anomalies in England and Wales. 
METHODS: We obtained congenital anomaly data from the National Congenital Anomalies System,
regional registries, and the national terminations registry; THM data were obtained from water
companies. Total THM (< 30, 30 to < 60, ≥ 60 µg/L), total brominated exposure (< 10, 10 to < 20,
≥ 20 µg/L), and bromoform exposure (< 2, 2 to < 4, ≥ 4 µg/L) were modeled at the place of resi-
dence for the ﬁrst trimester of pregnancy. We included 2,605,226 live births, stillbirths, and termi-
nations with 22,828 cases of congenital anomalies. Analyses using ﬁxed- and random-effects models
were performed for broadly deﬁned groups of anomalies (cleft palate/lip, abdominal wall, major
cardiac, neural tube, urinary and respiratory defects), a more restricted set of anomalies with better
ascertainment, and for isolated and multiple anomalies. Data were adjusted for sex, maternal age,
and socioeconomic status. 
RESULTS: We found no statistically significant trends across exposure categories for either the
broadly deﬁned or more restricted sets of anomalies. For the restricted set of anomalies with iso-
lated defects, there were signiﬁcant (p < 0.05) excess risks in the high-exposure categories of total
THMs for ventricular septal defects [odds ratio (OR) = 1.43; 95% confidence interval (CI),
1.00–2.04] and of bromoform for major cardiovascular defects and gastroschisis (OR = 1.18;
95% CI, 1.00–1.39; and OR = 1.38; 95% CI, 1.00–1.92, respectively). 
CONCLUSION: In this large national study we found little evidence for a relationship between THM
concentrations in drinking water and risk of congenital anomalies. 
KEY WORDS: chlorination, congenital anomalies, disinfection by-products, trihalomethanes. Environ
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[Online 6 November 2007]Severn Trent for 1993–1998 from a previous
study in these areas (Toledano et al. 2005),
and for all of the companies for 1998–2001;
these data were directly provided by the water
companies and checked by the study team.
The main method of disinfection during the
study period was chlorination, with a few
regions having additional chloramination.
Ozone was often used primarily for removal
of organic material, but it also would have
acted as a disinfectant.
Exposure data. We used THM concentra-
tions as the marker for chlorine disinfection
by-products. Water samples were routinely
collected and analyzed from each water zone
using random samples from each consumer’s
tap. Under regulations in force at the time, the
standard sampling frequency for THMs was a
minimum of four samples per year. However,
if there was a breach of the standard of
100 µg/L for total THMs, the sampling fre-
quency increased to a minimum of 12 or
24 per year, depending on the zone size.
Conversely, if the total THM concentration
was consistently < 50% of the standard, a
reduced frequency of at least one per year
could have been used. 
Because of the small number of THM
measurements in some water zones, the need
for quarterly (3 month) estimates (to allow for
trimester-weighted exposure estimates), and
the problem of measurements below the limit
of detection (LOD), it was necessary to model
the raw THM data to obtain more robust
estimates of the mean THM concentration in
each zone. This was done using a hierarchical
mixture model in the software WinBUGS
(Bayesian inference using Gibbs sampling)
(Spiegelhalter et al. 1996), as described
elsewhere (Whitaker et al. 2005). Brieﬂy, mod-
eling was carried out separately for each water
company and year. The model calculated the
mean annual individual THM concentrations
for each water zone and subsequently assigned
an estimated water source type to each water
zone, depending on the four THM levels
within each zone. We ﬁtted a three-component
mixture model in which zones were assumed to
belong to one or some mixture of three com-
ponents that we labeled “ground,” “lowland
surface,” and “upland surface” waters (the com-
ponents may not strictly correspond to these
three water source types; we simply aimed to
group waters with similar THM proﬁles, which
are more likely to be shared among water of the
same source type). The hierarchical model
enabled zones to “borrow” information from
other zones with the same water source type.
This resulted in more stable estimates for zones
where few samples were taken. For measure-
ments below the LOD, we used our model to
obtain an estimate between zero and the LOD
(rather than arbitrarily assigning one-half or
two-thirds the LOD, which is common prac-
tice). We took into account seasonal variation
by estimating a quarterly effect common to all
zones supplied by the same source type.
Congenital anomaly data. Individual post-
coded records were extracted from the
national births, stillbirths, terminations, and
congenital anomalies registers [National
Congenital Anomalies System (NCAS)] held
at the UK Small Area Health Statistics Unit
(SAHSU). In addition, individual postcoded
records were obtained from the regional reg-
istries via the British Isles Network of
Congenital Anomaly Registers (BINOCAR),
which covers about 50% of the population of
England and Wales (Figure 2). We merged the
data from the national and regional registries to
obtain one numerator database. Duplicate
records across data sets were removed, with
regional registry records prioritized. We used
national and regional registry region bound-
aries, as defined by the Office for National
Statistics, to delineate NCAS and BINOCAR
regions. The main analyses focused on broad
categories of congenital anomalies: cleft
lip/palate {International Classification of
Diseases, 10th Revision [ICD-10; World
Health Organization (WHO) 1992] codes
Q35–Q37}; diaphragmatic hernia and
abdominal wall defects (Q79); major cardiac
defects (Q20–Q28); NTDs (Q00, Q01, and
Q05); urinary tract defects (Q60–Q64); and
respiratory defects (Q30–Q34).
We conducted further analyses using
restricted groups of congenital anomalies that
were considered to be etiologically coherent,
with better ascertainment, deﬁned as follows:
abdominal wall defects (ICD-10 codes
Q79.0, Q79.1, Q79.2, and Q79.3), major
cardiac defects (Q20, Q21.2, Q21.3, Q22,
Q23, Q25.1–Q25.9, and Q26), urinary tract
defects (Q60, Q61, Q62, and Q64, but
excluding Q62.0, Q64.8, and Q64.9), and
respiratory defects (Q33). In addition we con-
ducted separate analyses for cleft palate
(ICD-10 code Q35), cleft lip with and with-
out cleft palate (Q36–Q37.99), exomphalos
(Q79.2), gastroschisis (Q79.3), hypoplastic
left heart syndrome (Q23.4), ventricular sep-
tal defects (Q21.0), and two subsets of uri-
nary tract defects including renal disease
(Q60 and Q61), and obstructive disease
(Q62 and Q64). We also included congenital
anomalies of the esophagus (Q39) in these
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Figure 1. Regions covered by water companies included in the analyses.
Abbreviations: ESW, Essex and Suffolk Water; SW, Southern Water; TW,
Thames Water. The white areas were not included in the study.
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Figure 2. Regions covered by regional congenital anomalies registries.
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Nanalyses. For earlier years (before 1995), we
bridged ICD-9 (WHO 1977) and ICD-10
(WHO 1992) codes manually. We conducted
further analyses excluding cases with anomalies
that were found to be part of a chromosomal
syndrome (i.e., chromosomal anomalies, any
mention of ICD-10 code Q9), as well as exam-
ining those cases with isolated anomalies only. 
The number of anomalies recorded per
baby was known to vary across BINOCAR
regions, with some regional registries more
likely to register a more detailed number of
minor anomalies for each baby than others.
We did not consider it appropriate, therefore,
to classify all babies registered with one
anomaly as “isolated” and all those registered
with more than one anomaly as having “mul-
tiple anomalies.” Instead, we devised an iso-
lated/multiple classiﬁcation that we judged to
be largely unaffected by differential reporting
of minor anomalies. First, we compiled a list
of all other major anomalies not already
included in the study [i.e., ICD-10 codes
Q11*, Q12*, Q13.0, Q41*, Q42*, Q54*,
Q55.5, Q55.6, Q66.0, Q68*, Q71*, Q72*,
Q89.3 (“*” indicates any subcategory of the
code)]. Classiﬁcation was then undertaken for
all broad and restricted category analyses as
follows (with the exception of abdominal wall
defects): babies were classiﬁed as “multiple” if
they had more than one anomaly that fell into
more than one of the six broad categories (i.e.,
cleft lip/palate, abdominal wall, major cardiac,
NTD, urinary, respiratory) or if they had one
(or more) anomalies from one of the six broad
categories together with one (or more) from
the list of additional major anomalies above.
For abdominal wall anomalies and gastro-
schisis (ICD-10 code Q79.3) and exomphalos
only (Q79.2), classiﬁcation of “multiple” was
as described above, with the addition that, if
more than one anomaly was registered from
within the same broad abdominal wall cate-
gory (ICD-10 code Q7*), the baby was also
classified as having “multiple” anomalies.
Thus, for a baby to be classiﬁed as having an
“isolated” abdominal wall anomaly, there
could be only one abdominal wall code.
There was a total of 22,828 cases with con-
genital anomalies; 1,641 (7.2%) of these had a
chromosomal defect, 2,249 (9.9%) were classi-
fied as having multiple (nonchromosomal)
anomalies, and 18,938 (83.0%) were classiﬁed
as having isolated anomalies only.
The study population was deﬁned accord-
ing to the first possible date on which
THM data for the ﬁrst trimester was available
(i.e., 15 October 1993 for United Utilities
and Severn Trent; 15 October 1997 for
Northumbrian; and 15 October 1998 for all
other water regions) until 31 December 2001. 
GIS methods and data linkage. We cre-
ated a postcode to water-zone link using
point-in-polygon methods within the GIS to
allocate each postcode to its water supply
zone. Postcode locations were derived from
the historical postcode ﬁle for Great Britain,
developed by SAHSU. This file traces post-
codes back in time and assigns a grid coordi-
nate for each postcode in each year. To take
account of changes in the location of both
postcodes and water-zone boundaries over
time, we created a separate link for each year
of the study period.
We used the postcode of the maternal resi-
dence at the year of birth to identify the water
zone of interest and hence the appropriate
exposure status for each birth record. The latter
was obtained by first calculating a weighted
average of the modeled quarterly THM esti-
mates for the appropriate zone for the first
93 days of the pregnancy. For cases, a gesta-
tional age was generally available and the ﬁrst
93 days of pregnancy was calculated. Where
gestational age was missing, we assigned the
anomaly-speciﬁc average gestation weeks. The
weighting was based on the proportion of the
trimester falling into each quarterly period.
Where the pregnancy was < 93 days, for exam-
ple, for terminations, we used the whole preg-
nancy time period. For noncases, we had to
assume that births had gone to term when cal-
culating the ﬁrst 93 days of the pregnancy, as
data on gestation weeks at birth are not
recorded on the birth records. Finally, the
weighted average THM estimate associated
with each birth record was categorized into one
of three predeﬁned exposure categories: con-
centrations of total THMS (TTHMs; < 30,
30 to < 60, and ≥ 60 µg/L), total brominated
THMs (< 10, 10 to < 20, and ≥ 20 µg/L), and
bromoform (< 2, 2 to < 4, and ≥ 4 µg/L).
These were chosen with reference to the pub-
lished literature on the possible associations of
birth outcomes with THMsand with regard to
the joint distribution of numbers of births and
THM concentrations across the water regions.
Exclusions and study size. We excluded a
total of 49,558 pregnancy outcomes, including
377 with congenital anomalies. The main rea-
sons for exclusion were either that no exposure
estimates were available and/or that lagging for
the critical exposure period was not possible.
This left 2,605,226 births for analysis, includ-
ing live births, stillbirths, and terminations. 
Statistical analyses. Using the statistical
package R, we carried out descriptive analysis
and univariate and multiple logistic regression
modeling with adjustment for the following
potential confounders: a) maternal age (for
which individual level information was avail-
able) categorized as < 21, 21–25, 26–30,
31–35, and > 35 years; b) socioeconomic status
categorized into quintiles of an areal depriva-
tion index (Carstairs and Morris 1991) accord-
ing to location of the postcode of maternal
residence at the time of birth, using a combina-
tion of four indicators at the level of 2001 cen-
sus output area (percentage of people with no
car, in overcrowded housing, with head of
household in social class IV or V, and percent-
age of men unemployed); c) year of birth; and
d) registry (BINOCAR or NCAS region).
Interactions between THM exposure and
potential confounding variables were tested
where appropriate. 
We conducted analyses by individual
BINOCAR/NCAS region, and tested for
heterogeneity of risks associated with THM
exposure across the BINOCAR/NCAS
regions. We conducted analyses using both
fixed-effects and random-effects models.
Nieuwenhuijsen et al.
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Table 2. Pearson correlations between various species of THMs at water-zone level.
Bromoform Chloroform DBCM TBROM TTHM
BDCM –0.11 0.46 0.50 0.73 0.74
Bromoform –0.44 0.61 0.54 –0.18
Chloroform –0.30 –0.05 0.90
DBCM 0.93 0.12
TBROM 0.38
DBCM, dibromochloromethane; TBROM, total brominated species (BDCM, DBCM, and bromoform). 
Table 1. Characteristics of the THM exposure categories (µg/L).
No. of 
Mean ± SD Minimum Maximum No.a water zones
Total THMs
Low 16.4 ± 8.7 0.5 < 30.0 1,062,158 1,289
Medium 43.6 ± 8.6 30.0 < 60.0 1,109,346 1,220
High 72.2 ± 10.1 60.0 130.9 433,722 698
Total brominated THMs
Low 6.6 ± 2.4 0.4 < 10.0 816,863 1,175
Medium 14.2 ± 2.9 10.0 < 20.0 1,187,932 1,345
High 28.3 ± 8.4 20.0 74.9 600,431 828
Bromoform
Low 0.9 ± 0.5 0.0 < 2.0 1,575,323 1,417
Medium 2.9 ± 0.6 2.0 < 4.0 538,570 1,000
High 6.7 ± 3.2 4.0 51.8 491,333 775
aNumber of live births, stillbirths, and terminations. Where there was signiﬁcant (p < 0.05) hetero-
geneity, we used results of the random-effects
model to obtain an overall summary estimate
of the effect of THM, allowing for hetero-
geneity in the region-specific estimates
(Dersimonian and Laird 1986). Where there
was no evidence of heterogeneity, we present
the ﬁxed-effects models.
Results
Descriptive statistics. Tables 1 and 2 describe
THM concentrations by exposure categories
and the correlation of the various individual
THMs. Mean TTHM concentrations ranged
from 16.4 µg/L in the low-exposure category
to 72.2 µg/L in the high-exposure category.
We observed the highest correlations between
total brominated THMs and dibromochloro-
methane (0.93), and between TTHM and
chloroform (0.90). 
The prevalence of each broad congenital
anomaly group by deprivation, sex, maternal
age, and BINOCAR/NCAS region is shown in
Table 3. The number of anomalies ranged
from 1,434 for respiratory defects to 8,809 for
major cardiac defects. We found higher preva-
lence of each anomaly when we compared the
most deprived areas to the most afﬂuent areas.
Prevalence in males and females was similar,
except for cleft lip/palate and urinary tract
defects, where prevalence was 50–100% higher
in males. We observed U-shaped relationships
between prevalence of congenital anomalies
and maternal age, except for NTDs where the
prevalence decreased with increasing maternal
age. The reported prevalence of each anomaly
was substantially higher in the BINOCAR
regions than in the NCAS regions, reﬂecting
better ascertainment. Rates also varied among
the regional registries (data not shown).
Regression models. Unadjusted (data not
shown) and adjusted analyses showed similar
risk estimates. We found no statistically signiﬁ-
cant trends across the three exposure categories
for total THMs, total brominated THMs, or
bromoform for either the broadly deﬁned or
more restricted sets of anomalies. The only
significant associations (p < 0.05) with the
broadly defined groups of anomalies was a
deficit risk of abdominal wall defects in the
high TTHM exposure category [odds ratio
(OR) = 0.81; 95% confidence interval (CI),
0.68–0.95] and an excess risk of major cardiac
defects in the medium (but not high) exposure
category of total brominated THMs (OR =
1.12; 95% CI, 1.01–1.23) (Table 4). For the
restricted set of isolated anomalies, we
observed statistically signiﬁcant excess risks for
TTHM in the high-exposure category of ven-
tricular septal defects (OR = 1.43; 95% CI,
1.00–2.04) and in the medium- (but not
high) exposure category for congenital anom-
alies of the esophagus (OR = 1.66; 95% CI
1.12–2.45). For bromoform, there was a sig-
niﬁcant excess in the high-exposure category
for both major cardiac defects (OR = 1.18;
95% CI, 1.00–1.39) and gastroschisis (OR =
1.38; 95% CI, 1.00–1.92) (Figure 3). 
We found no significant interactions
between TTHM exposure and any of the
potential confounders. Analyses of cases with
multiple anomalies showed no signiﬁcant asso-
ciation with THM concentrations, but the
numbers were small (data not shown).
Sensitivity analyses that excluded the NCAS
data made little difference to the overall results. 
Discussion
The present study is the largest study to date
to examine the relationship between THM
exposure and congenital anomalies, and the
Chlorination disinfection by-products and congenital anomalies
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Table 3. Prevalence rates (per 1,000) of various congenital anomalies by potential confounding variables.
No. of Cleft lip/palate Abdominal wall Major cardiac Neural tube Urinary tract Respiratory
births and No. of Prevalence No. of Prevalence No. of Prevalence No. of Prevalence No. of Prevalence No. of Prevalence
terminations cases (95% CI) cases (95% CI) cases (95% CI) cases (95% CI) cases (95% CI) cases (95% CI)
Total 2,605,226 3,736 1.43 2,267 0.87 8,809 3.38 3,334 1.28 5,315 2.04 1,434 0.55
(1.39–1.48) (0.84–0.91) (3.31–3.45) (1.24–1.32) (1.99–2.10) (0.52–0.58) 
Deprivation quintiles
1 (afﬂuent) 425,593 602 1.41 292 0.69 1,302 1.55 470 1.10 777 1.83 202 0.47
(1.31–1.53) (0.61–0.77) (1.43–1.67) (1.01–1.21) (1.70–1.96) (0.41–0.54)
2 442,019 585 1.32 300 0.68 1,419 1.60 483 1.09 830 1.88 203 0.46
(1.22–1.44) (0.61–0.76) (1.48–1.72) (1.00–1.19) (1.75–2.01) (0.40–0.53)
3 475,900 655 1.38 371 0.78 1,580 1.74 603 1.27 909 1.91 278 0.58
(1.27–1.49) (0.70–0.86) (1.63–1.86) (1.17–1.37) (1.79–2.04) (0.52–0.66)
4 514,593 729 1.42 587 1.14 1,880 1.79 724 1.41 1,165 2.26 328 0.64
(1.32–1.52) (1.05–1.24) (1.68–1.91) (1.31–1.51) (2.14–2.40) (0.57–0.71)
5 (deprived) 747,001 1,165 1.56 717 0.96 2,626 1.77 1054 1.41 1,633 2.19 422 0.56 
(1.47–1.65) (0.89–1.03) (1.67–1.86) (1.33–1.50) (2.08–2.29) (0.51–0.62)
Registry region
NCAS 1,060,401 1,020 0.96 552 0.52 1,322 1.25 905 0.85 1,112 1.05 174 0.16
(0.90–1.02) (0.48–0.57) (1.18–1.32) (0.80–0.91) (0.99–1.11) (0.14–0.19)
BINOCAR 1,544,825 2,716 1.78 1,715 1.12 7,487 4.90 2,429 1.59 4,203 2.75  1,260 0.82 
(1.71–1.84) (1.07–1.18) (4.79–5.01) (1.53–1.65) (2.67–2.83) (0.78–0.87)
Maternal age (years)
< 21  294,135 390 1.33 516 1.75 925 3.14 431 1.47 635 2.16 170 0.58
(1.20–1.46) (1.61–1.91) (2.95–3.35) (1.33–1.61) (2.00–2.33) (0.50–0.67)
21–25 550,562 806 1.46 538 0.98 1,615 2.93 746 1.35 1,122 2.04 289 0.52
(1.37–1.57) (0.90–1.06) (2.79–3.08) (1.26–1.46) (1.92–2.16) (0.47–0.59)
26–30 819,488 1,034 1.26 514 0.63 2,273 2.77 1,015 1.24 1,555 1.90 398 0.49
(1.19–1.34) (0.58–0.68) (2.66–2.89) (1.16–1.32) (1.81–1.99) (0.44–0.54)
31–35 660,909 860 1.30 410 0.62 1,903 2.88 805 1.22 1,201 1.82 320 0.48
(1.22–1.39) (0.56–0.68) (2.75–3.01) (1.14–1.31) (1.72–1.92) (0.43–0.54)
> 35  274,106 427 1.56 253 0.92 1,109 4.05 327 1.19 551 2.01 197 0.72
(1.42–1.71) (0.82–1.04) (3.82–4.29) (1.07–1.33) (1.85–2.18) (0.63–0.83)
Sex of babya
Male 1,332,251 1,034 0.78 408 0.31 1,232 0.92 196 0.15 1,134 0.85 159 0.12
(0.73–0.82) (0.28–0.34) (0.87–0.98) (0.13–0.17) (0.80–0.90) (0.10–0.14) 
Female 1,265,381 722 0.57 343 0.27 1,092 0.86 226 0.18 539 0.43 134 0.11
(0.53–0.61) (0.24–0.30) (0.81–0.92) (0.16–0.20) (0.39–0.46) (0.09–0.13)
aInformation on sex of baby was unavailable for terminations (2,636; 12%) and was not provided for all cases from local congenital anomaly registers (13,085; 57%).ﬁrst to examine the effects of bromoform on
congenital anomalies and the effects of THM
exposure on gastroschisis. We found little evi-
dence of a relationship between concentrations
of THMs and a wide spectrum of congenital
anomalies. There were no statistically signiﬁ-
cant exposure–response trends across the
exposure categories for any of the anomalies
studied. Statistically significant excess risks
were observed for isolated anomalies only for
ventricular septal defects and esophageal
anomalies in the high- and medium-exposure
categories, respectively, of TTHMs and for a
subset of major cardiac defects and gastroschi-
sis in the high-exposure category of bromo-
form. In the context of this study, these may
have been chance associations; there is still lit-
tle or no toxicologic evidence for reproductive
or teratogenic effects of bromoform, or other
DBPs (Nieuwenhuijsen et al. 2000a); also, the
concentrations of bromoform across our study
regions were generally very low, with only
19% of the population being exposed to levels
> 4 µg/L (high-exposure group). In the only
other epidemiologic study reporting bromo-
form levels, the mean level reported by Savitz
et al. (2006) at their brominated DBP site
(6.4 µg/L) was similar to the mean in our
high-exposure group; mean levels at their
other two sites were also low (0.1 and
0.6 µg/L). 
In contrast, the careful selection of subsets
of major cardiac defects, ventricular septal
defects, and gastroschisis as isolated anomalies
may have increased accuracy of case deﬁnition
(and reduced misclassiﬁcation). Furthermore,
Geter et al. (2005) suggested potential epige-
netic effects of bromoform and potential
mechanisms, such as alteration in DNA
methylation, that could result in effects on
cell proliferation/apoptosis; they also sug-
gested that increased homocysteine levels
could lead to oxidative stress, which also may
feed into cell birth/cell death balance. Further
study of these speciﬁc anomalies and bromo-
form exposure may be warranted.
Using color as a surrogate for DBP expo-
sure, Hwang et al. (2002) also found signiﬁ-
cant excess risks of ventricular septal defects.
Adjusted ORs were 1.63 (95% CI, 1.02–2.58)
and 1.81 (95% CI, 1.05–3.09) for the
medium- and high-exposure categories, respec-
tively. Hwang et al. (2002) and Cedergren
et al. (2002) found statistically signiﬁcant asso-
ciations between major cardiac defects and
chlorinated water/concentrations of TTHM
> 10 µg/L. Other studies have reported no
associations with cardiac defects (Bove et al.
1995; Dodds and King 2001; Dodds et al.
1999; Magnus et al. 1997; Shaw et al. 2003).
Unlike the present study, three other studies
reported significant positive associations
between chlorinated water and urinary tract
defects (Aschengrau et al. 1993; Hwang et al.
2002; Magnus et al. 1999), and two of three
studies to date have found a signiﬁcant posi-
tive association with respiratory defects
(Aschengrau et al. 1993; Hwang et al. 2002).
Klotz and Pyrch (1999) found a statistically
significant association between TTHM and
NTDs, but not with concentrations of halo-
acetonitriles and haloacetates. Also, the effects
were most pronounced in offspring of women
who did not take supplementary vitamins, but
these ﬁndings were not replicated in the study
by Shaw et al. (2003). Moreover, inclusion of
information on ingestion, showering, bathing,
and swimming made little difference to the risk
estimates (Klotz and Pyrch 1999). In a meta-
analysis, Hwang and Jaakkola (2003) reported
a signiﬁcant association between chlorination
by-product exposure and risk of NTDs and
urinary system defects, but results for respira-
tory system, major cardiac, and oral cleft
defects were heterogeneous and inconclusive. 
Various factors may have contributed to
the lack of consistency between studies,
including differences in exposure and out-
come definitions, case ascertainment, expo-
sure misclassification (due in part to the
relatively crude methods of exposure assess-
ment), differences in the composition of
DBPs in the water supply, and low statistical
power due to small sample size. In the present
study we addressed a number of these weak-
nesses—specifically by paying careful atten-
tion to case definition, the use of subsets of
anomalies, the large sample size, and the use
of modeled trimester-weighted THM expo-
sure estimates—to improve exposure classiﬁ-
cation. The next largest study included
approximately 285,000 births and 5,764 cases
of congenital anomalies (Hwang et al. 2002).
One of the main limitations of registry-
based studies of congenital anomalies is that
ascertainment is geographically variable and
often incomplete. In the United Kingdom,
the NCAS ascertains only around 40% of the
congenital anomalies compared with the
BINOCAR registries (Boyd et al. 2005).
Similarly, we found a substantial difference in
prevalence rates between the NCAS and
BINOCAR registries, as well as differences in
prevalence rates between the various regional
registries, which might in part reflect differ-
ences in methods of ascertainment and com-
pleteness of reporting (Rankin et al. 2005). In
the present study, analysis of the BINOCAR
data alone (where case ascertainment was
higher) made little difference to the overall
results. Variation in reporting rates is
unavoidable when registration is not a statu-
tory requirement, unlike, for example, the
registration of births or deaths, although some
anomalies such as gastroschisis have good and
consistent ascertainment across registries.
Such geographic variations should not bias
study results, provided that completeness of
reporting is unrelated to the exposure of inter-
est. We used an isolated/multiple classifica-
tion among a restricted set of anomalies to
overcome differential reporting of minor
anomalies, but there was some indication that
such differential reporting may have occurred.
We found opposing trends between NCAS
regions (where ascertainment was highest in
the high-exposure categories) and BINOCAR
regions (where ascertainment was lowest in
Nieuwenhuijsen et al.
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Table 4. The number of cases and adjusted overall ORs (95% CIs) for various congenital anomalies by TTHM category.
Cleft lip palate Abdominal wall defects Major cardiac defects NTDs Urinary tract defects Respiratory defects
Category No. OR (95%CI) No. OR (95%CI) No. OR (95%CI) No. OR (95%CI) No. OR (95%CI) No. OR (95%CI)
TTHM
Low 1,482 1.00 970 1.00 2,948 1.00 1,466 1.00 2,019 1.00 664 1.00
Medium 1,505 0.97 (0.88–1.05) 973 0.97 (0.87–1.08) 3,709 0.99 (0.82–1.20) 1,437 0.98 (0.85–1.13) 2,320 1.06 (0.91–1.23) 588 0.98 (0.86–1.11)
High 530 0.94 (0.83–1.06) 288 0.81 (0.68–0.95) 1,166 0.96 (0.78–1.17) 421 0.91 (0.73–1.13) 724 0.94 (0.78–1.14) 121 1.00 (0.80–1.26)
TBROM 
Low 1,242 1.00 769 1.00 2,543 1.00 1,226 1.00 1,718 1.00 535 1.00
Medium 1,570 0.98 (0.89–1.06) 1,035 1.03 (0.92–1.14) 3,957 1.12 (1.01–1.23) 1,446 0.98 (0.85–1.14) 2,412 1.09 (0.98–1.20) 574 1.13 (0.87–1.46)
High 705 0.96 (0.86–1.07) 427 1.02 (0.89–1.17) 1,323 1.13 (0.93–1.37) 652 0.90 (0.79–1.03) 933 1.05 (0.89–1.25) 264 1.09 (0.80–1.49)
Bromoform
Low 2,206 1.00 1,401 1.00 5,263 1.00 2,074 1.00 3,361 1.00 896 1.00
Medium 697 1.06 (0.96–1.18) 438 1.01 (0.83–1.22) 1,326 1.07 (0.90–1.27) 663 1.01 (0.84–1.22) 921 1.01 (0.92–1.11) 291 1.07 (0.91–1.27)
High 614 1.01 (0.88–1.16) 392 1.15 (0.82–1.62) 1,234 1.04 (0.87–1.24) 587 0.96 (0.83–1.11) 781 0.96 (0.78–1.18) 186 0.98 (0.78–1.23)
TTHM category (low, < 30 µg/L; medium, 30–60 µg/L; high, > 60 µg/L), TBROM category (low, < 10 µg/L; medium, 10–20 µg/L; high, > 20 µg/L), and bromoform category (low, < 2 µg/L;
medium, 2–4 µg/L; high, > 4 µg/L). Overall summary estimates were obtained from meta-analysis combining the registry-speciﬁc exposure ORs adjusted for Carstairs deprivation quintile,
year, water company, and mother’s age. The meta-analyses incorporated random effects where necessary to allow for heterogeneity between registries. the high-exposure categories), although no
such trends were apparent for the brominated
compounds. Whether such trends reﬂect dif-
ferences in case deﬁnition or completeness of
reporting across registries and exposure cate-
gories, and whether these may have led to
important biases, is difﬁcult to establish with
any certainty. 
Further limitations are the lack of infor-
mation on gestation age and on mobility of
women during pregnancy, both of which may
have led to exposure misclassification, and
hence attenuation in risk estimates. 
To take into account heterogeneity
between regions served by different registries,
we conducted the analyses separately for each
registry and used meta-analysis to obtain sum-
mary ORs. If THMs are an imperfect proxy
for other by-products, then heterogeneity in
risk estimates between regions might be
expected, and a random-effects model may be
most appropriate. If the THMs are the sub-
stances of interest, a ﬁxed-effects model may
be the most appropriate. In the present study,
the choice of model made little difference to
magnitude of the risk estimates, although the
confidence intervals were slightly wider for
random-effects models.
Although one of the main strengths of our
study is its size, this and its retrospective
nature simultaneously limit the options avail-
able for exposure assessment. Whereas the
approach used here appears to provide valid
estimates of THM exposure for epidemiologic
study (Keegan et al. 2001; Nieuwenhuijsen
et al. 2000b; Toledano et al. 2005; Whitaker
et al. 2003), the lack of association between
THMs and congenital anomalies does not
preclude the possibility of an association at
the individual level, or between other DBPs
and congenital anomalies. THM concentra-
tions may not be a good marker of other by-
products (e.g., haloacetates) that have recently
been implicated with respect to adverse birth
outcomes (Hinckley et al. 2006; Porter et al.
2005; Wright et al. 2004). For example, we
reported only a moderate correlation between
THMs and haloacetic acids in parts of the
study area (Malliarou et al. 2005). However,
among > 500 different DBPs that have been
identified (Richardson 1998), THMs and
haloacetic acids are present in by far the great-
est concentrations; others are present at much
smaller concentrations, usually < 1 µg/L. 
Currently there is no plausible biological
mechanism by which chlorination by-products
could cause congenital anomalies, particularly
at low concentrations. Nonetheless, the policy
of minimizing the concentrations of chlorina-
tion by-products in the public water supply
by removing the natural organic precursors,
while simultaneously maintaining the level of
protection from disinfection, seems appropri-
ate in view of concerns about possible adverse
reproductive health effects (Nieuwenhuijsen
et al. 2000a, 2000b). The WHO has contin-
ued to emphasize that high levels of protec-
tion from disinfection should never be
compromised in trying to reduce disinfection
by-product concentrations; our data do not
detract from that view.
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